Compare Stocks → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ADXNYSE:DNPNASDAQ:IBBNYSE:NUVNYSE:PTY Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADXAdams Diversified Equity Fund$18.40-1.1%$19.10$15.30▼$19.60$2.28B1.01176,068 shs232,671 shsDNPDNP Select Income Fund$8.80+0.3%$8.89$8.09▼$11.18$3.12B0.47631,699 shs347,227 shsIBBiShares Biotechnology ETF$124.72+0.1%$135.09$111.83▼$141.16$6.93B0.841.81 million shs2.00 million shsNUVNuveen Municipal Value Fund$8.51+0.5%$8.67$7.86▼$8.93$1.77B0.33424,191 shs456,299 shsPTYPIMCO Corporate & Income Opportunity Fund$13.71+0.1%$14.38$11.92▼$15.10$2.10B0.97628,234 shs692,213 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADXAdams Diversified Equity Fund-0.69%-3.77%-3.37%+4.23%+18.23%DNPDNP Select Income Fund+0.63%-2.01%-2.93%+2.87%-16.82%IBBiShares Biotechnology ETF-0.99%-5.81%-8.45%-7.80%-6.44%NUVNuveen Municipal Value Fund-0.06%-0.47%-2.08%-0.59%-3.63%PTYPIMCO Corporate & Income Opportunity Fund+0.15%-3.83%-5.75%+0.81%+7.29%Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADXAdams Diversified Equity FundN/AN/AN/AN/AN/AN/AN/AN/ADNPDNP Select Income FundN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/AN/AN/AN/AN/AN/AN/APTYPIMCO Corporate & Income Opportunity FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADXAdams Diversified Equity FundN/AN/AN/AN/ADNPDNP Select Income FundN/AN/AN/AN/AIBBiShares Biotechnology ETF0.00N/A$155.7324.86% UpsideNUVNuveen Municipal Value FundN/AN/AN/AN/APTYPIMCO Corporate & Income Opportunity FundN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADXAdams Diversified Equity Fund$567.05M4.02N/AN/AN/A∞DNPDNP Select Income FundN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/AN/AN/AN/AN/APTYPIMCO Corporate & Income Opportunity Fund$221.53M9.47N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADXAdams Diversified Equity FundN/AN/A0.00∞N/AN/AN/AN/A5/26/2024 (Estimated)DNPDNP Select Income FundN/AN/A0.00∞N/AN/AN/AN/A6/28/2024 (Estimated)IBBiShares Biotechnology ETFN/AN/A16.28∞N/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/A0.00∞N/AN/AN/AN/AN/APTYPIMCO Corporate & Income Opportunity FundN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADXAdams Diversified Equity Fund$1.307.07%-3.64%N/A1 YearsDNPDNP Select Income Fund$0.788.86%N/AN/AN/AIBBiShares Biotechnology ETF$0.400.32%N/AN/AN/ANUVNuveen Municipal Value Fund$0.344.00%N/AN/AN/APTYPIMCO Corporate & Income Opportunity Fund$1.4210.36%-2.96%N/AN/ALatest IBB, DNP, NUV, ADX, and PTY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024DNPDNP Select Income Fund--$0.06508.6%6/28/20246/28/20247/10/20243/19/2024DNPDNP Select Income Fund--$0.06508.6%5/31/20245/31/20246/10/20244/18/2024ADXAdams Diversified Equity FundQuarterly$0.051.09%5/16/20245/17/20245/31/20243/15/2024DNPDNP Select Income FundMonthly$0.06508.6%4/29/20244/30/20245/10/20244/1/2024NUVNuveen Municipal Value FundMonthly$0.02904.03%4/12/20244/15/20245/1/20244/1/2024PTYPIMCO Corporate & Income Opportunity FundMonthly$0.11889.57%4/10/20244/11/20245/1/20243/1/2024NUVNuveen Municipal Value FundMonthly$0.02904.01%3/14/20243/15/20244/1/20243/1/2024PTYPIMCO Corporate & Income Opportunity FundMonthly$0.11889.98%3/8/20243/11/20244/1/20243/20/2024IBBiShares Biotechnology ETFQuarterly$0.12603/21/20243/22/20243/27/20242/1/2024NUVNuveen Municipal Value FundMonthly$0.02903.93%2/14/20242/15/20243/1/20242/1/2024PTYPIMCO Corporate & Income Opportunity FundMonthly$0.118810.2%2/9/20242/12/20243/1/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADXAdams Diversified Equity Fund28.41%DNPDNP Select Income Fund8.51%IBBiShares Biotechnology ETF62.45%NUVNuveen Municipal Value Fund22.50%PTYPIMCO Corporate & Income Opportunity Fund10.25%Insider OwnershipCompanyInsider OwnershipADXAdams Diversified Equity Fund0.11%DNPDNP Select Income Fund0.06%IBBiShares Biotechnology ETFN/ANUVNuveen Municipal Value Fund1.00%PTYPIMCO Corporate & Income Opportunity FundN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableADXAdams Diversified Equity FundN/A124.01 million123.88 millionNot OptionableDNPDNP Select Income FundN/A354.86 million354.64 millionNot OptionableIBBiShares Biotechnology ETFN/A55.55 millionN/AOptionableNUVNuveen Municipal Value Fund640207.54 million205.47 millionNot OptionablePTYPIMCO Corporate & Income Opportunity Fund147,000153.08 millionN/ANot OptionableIBB, DNP, NUV, ADX, and PTY HeadlinesSourceHeadlinePIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Stock Price Crosses Below 200-Day Moving Average of $13.69americanbankingnews.com - April 19 at 4:24 AMThe Bond Market Is Booming (and these 9% Dividends Are the Best Play)marketbeat.com - April 17 at 10:03 PMPIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Sees Unusually-High Trading Volumeamericanbankingnews.com - April 13 at 5:58 AMShort Interest in PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Drops By 96.6%marketbeat.com - April 10 at 11:15 PMPTY: Monthly Paying CEF That Could Benefit From Rate Cutsseekingalpha.com - April 10 at 3:55 PMPTY: Strong Gains Despite Worsening Prospects, Time To Rotate Outseekingalpha.com - April 7 at 7:50 AMPIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Reaches New 1-Year High at $15.00marketbeat.com - April 4 at 10:47 AMPIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Plans $0.12 Monthly Dividendmarketbeat.com - April 3 at 8:52 AMPIMCO Corporate & Income Opportunity Fund (NYSE:PTY) Sets New 1-Year High at $15.00marketbeat.com - March 26 at 5:46 PMPimco Closed-End Funds Declare Monthly Common Share Distributionsglobenewswire.com - March 1 at 5:16 PMBond Manager PIMCO Withdraws From Climate Action 100+ Investor Coalitionmoney.usnews.com - February 16 at 2:10 PMPTY Has Been Holding Steady While Generating Monthly Income, Yielding Over 10%seekingalpha.com - February 12 at 9:00 AMInvest With The Best: PDOseekingalpha.com - February 5 at 1:07 PM2 Stocks Yielding Above 10% That Could Be Subject To Dividend Cutseekingalpha.com - February 2 at 12:54 PMPTY: Buy PIMCO's Flagship CEF While Rates Stay Highseekingalpha.com - January 31 at 11:18 AMPIMCO Corporate & Income Opportunity (PTY)investing.com - January 31 at 5:46 AMPIMCO Update (Quick) | January 2024 | Watch The NAV Momentum Turnseekingalpha.com - January 17 at 7:58 AMPIMCO Corporate & Income Opportunity Fds's Dividend Analysisfinance.yahoo.com - December 8 at 7:48 AMPDO: Lessons I've Learned From PTYseekingalpha.com - December 8 at 7:06 AMPTY: Still Appealing, Yielding 10.41% At End Of The Fed's Tightening Cycleseekingalpha.com - November 7 at 8:45 AMHow To Secure 9.5% Dividends For Years And Yearsforbes.com - October 24 at 8:16 AMPTY: The Risk Profile Still Makes Me Uneasyseekingalpha.com - October 3 at 12:29 PMPTY: Risks Lurking Behind 10% Yieldseekingalpha.com - September 8 at 7:34 AMPTY: Substantial Tail Risk Required To Slow This CEF Downseekingalpha.com - August 21 at 7:25 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeBiotech Sector Nears Breakout: Will it Outperform in Q2?April 3, 2024 6:10 AMView Biotech Sector Nears Breakout: Will it Outperform in Q2?Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?April 16, 2024 6:15 AMView Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?All Headlines Company DescriptionsAdams Diversified Equity FundNYSE:ADXAdams Diversified Equity Fund, Inc. is a publicly owned investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm The firm is actively engaged in businesses, including commodity pool operator or commodity trading advisor. The firm launches equity. NA The firm employs combination of fundamental, technical, quantitative modelling, and macro-economic analysis to make its investment. The firm conduct external research to make its investment. The firm was formerly known as The Adams Express Company. Adams Diversified Equity Fund, Inc. was founded in 1929 and is based in Baltimore, Maryland.DNP Select Income FundNYSE:DNPDNP Select Income Fund Inc. is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds. It seeks to invest in stocks of companies operating in the Utility sector. The fund invests in stocks of companies across all market capitalizations. It benchmarks the performance of its portfolio against the S&P 500 Utilities Index and Barclays Capital U.S. Utility Bond Index. DNP Select Income Fund Inc. was formed on November 26, 1986 and is domiciled in the United States.iShares Biotechnology ETFNASDAQ:IBBiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Nuveen Municipal Value FundNYSE:NUVNuveen Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund also invests some portion of its portfolio in derivative instruments. It invests in undervalued municipal securities and other related investments the income, exempt from regular federal income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Municipal Value Fund, Inc. was formed on April 8, 1987 and is domiciled in the United States.PIMCO Corporate & Income Opportunity FundNYSE:PTYPIMCO Corporate & Income Opportunity Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets across the globe. It invests in corporate debt obligations rated in the lowest investment grade category Baa or BBB and in the highest non-investment grade category Ba or BB. The fund focuses on intermediate maturity bonds across multiple industries and sectors. It employs fundamental analysis along with top-down approach to make its fixed income investments. The fund uses in-house research to make its investments. PIMCO Corporate Opportunity Fund was founded on December 27, 2002 and is domiciled in United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.